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Abstract
Background: High HIV incidence has been detected among men who have sex with men (MSM) in Thailand, but
the relationship and timing of HIV, herpes simplex virus 2 (HSV-2), and syphilis is unknown. This analysis measures
incidence, temporal relationships, and risk factors for HIV, HSV-2, and syphilis among at-risk MSM in the Bangkok
MSM Cohort Study.
Methods: Between April 2006 and December 2010, 960 men negative for HIV, HSV-2, and syphilis at entry enrolled
and contributed 12–60 months of follow-up data. Behavioral questionnaires were administered at each visit; testing
for HIV antibody was performed at each visit, while testing for syphilis and HSV-2 were performed at 12 month
intervals. We calculated HIV, HSV-2, and syphilis incidence, assessed risk factors with complementary log-log
regression, and among co-infected men, measured temporal relationships between infections with Kaplan-Meier
survival analysis and paired t-test.
Results: The total number of infections and incidence density for HIV, HSV-2, and syphilis were 159 infections and
4.7 cases/100 PY (95 % Confidence Interval (CI): 4.0–5.4), 128 infections and 4.5/100 PY (95 % CI: 3.9–5.5), and 65
infections and 1.9/100 PY (95 % CI: 1.5–2.5), respectively. Among men acquiring >1 infection during the cohort
period, mean time to HIV and HSV-2 infection was similar (2.5 vs. 2.9 years; p = 0.24), while syphilis occurred
significantly later following HIV (4.0 vs. 2.8 years, p < 0.01) or HSV-2 (3.8 vs. 2.8 years, p = 0.04) infection. The
strongest independent predictor of any single infection in adjusted analysis was acquisition of another infection;
risk of syphilis (Adjusted Hazards Ratio (AHR) = 3.49, 95 % CI: 1.89–6.42) or HIV (AHR = 2.26, 95 % CI: 1.47–3.48)
acquisition during the cohort was significantly higher among men with incident HSV-2 infection. No single
independent behavioral factor was common to HIV, HSV-2, and syphilis acquisition.
Conclusion: HIV and HSV-2 incidence was high among this Thai MSM cohort. However, acquisition of HIV and
co-infection with either HSV-2 or syphilis was low during the time frame men were in the cohort. Evaluation of
behavioral risk factors for these infections suggests different risks and possible different networks.
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Background
HIV prevalence among men who have sex with men
(MSM) continues to increase globally, with Southeast
Asia experiencing high HIV prevalence and incidence
rates in several settings [1–3]. Prevalent sexually trans-
mitted infections (STIs), particularly herpes simplex 2
virus (HSV-2) and Treponema pallidum (TP) (syphilis),
are established risk factors for HIV acquisition and
transmission in MSM [4–8]. Several longitudinal studies
establish that prevalent or incident HSV-2 or syphilis in-
fection increases the likelihood of HIV acquisition but
few studies evaluate the temporal linkages between these
events [9–12].
Evidence to date indicates ulcerative STIs foster HIV
acquisition, but the degree to which this occurs appears
variable [5]. Two observational cohort studies suggest
that syphilis or HSV-2 acquisition precede and poten-
tially increase the risk of HIV acquisition [11, 12].
However, an intervention using acyclovir to reduce
HSV-2 outbreaks in MSM did not significantly reduce
HIV acquisition [13]. MSM cohorts of 12 months
duration or less in China and Argentina detected moder-
ate to high HIV and syphilis incidence with no cases of
mutual co-infection [14–16]. Few analyses to date follow
MSM negative for HIV, HSV-2, and syphilis at cohort
entry to allow evaluation of incident events relative to
each other.
In the Bangkok MSM Cohort Study (BMCS), HIV
prevalence and incidence depict a worrisome situation.
HIV prevalence exceeded 20 % and longitudinal analysis
revealed an incidence density of 5.9/100 person-years
(PY); factors independently associated with HIV preva-
lence and incidence included prevalent syphilis and
HSV-2 infection [2]. Both prevalent HSV-2 and syphilis
were also independently associated with each other in a
separate baseline analysis [17]. Analysis of the relative
timing of acquisition between each infection may pro-
vide valuable insights as to whether biological or behav-
ioral risk factors are driving the HIV epidemic among
MSM in Bangkok and elsewhere. The purpose of this
analysis was to assess the temporal associations between
and risk factors for HIV, HSV-2, and syphilis infections
over 12 months of follow-up in a cohort of MSM at risk
for all three infections in Bangkok, Thailand.
Methods
Study population
Between April 2006 and January 2008, and September
2009 and November 2010, 1,744 MSM enrolled in the
BMCS. Analyses are limited to those entering the cohort
without serologic evidence of HIV, HSV-2, or syphilis in-
fection at entry, and contributing follow-up data for at
least 12 months. The study methodology is described in
detail elsewhere [2, 17]. Briefly, participants were Thai
men aged ≥18 years, residing in the Bangkok metropol-
itan area who reported penetrative oral or anal sex with
another man in the past six months, and were able to
provide written informed consent. Participants were re-
cruited by outreach workers at venues regularly patron-
ized by MSM, via MSM-targeted websites, and directly
by study staff and care providers at a male sexual health
clinic. Interested men made an appointment at the Silom
Community Clinic, the site of formal screening, written
informed consent, enrollment, and all other study
activities [2, 17]. The study protocol was approved by
the Ethical Review Committee for Research in Human
Subjects of the Thailand Ministry of Public Health, and
by an Institutional Review Board of the U.S. Centers for
Disease Control and Prevention.
Study activities
At baseline, participants completed a questionnaire via
an audio-computer-assisted self-interview (ACASI); HIV
counseling and testing; a physical exam inclusive of oro-
pharyngeal, rectal and urine sampling for N. gonorrhea
(NG) and C. trachomatis (CT) screening and drug-use
testing; and phlebotomy for serologic screening. Follow-
up visits were scheduled at four-month intervals, com-
prising the same sequence of activities with the excep-
tion of syphilis and HSV-2 screening, which involved
follow-up testing at 12 month intervals for a maximum
period of 60 months, and urine drug, NG, and CT
screening was not repeated at follow-up visits. All
participants received HIV and STI prevention counsel-
ing, with lubricants and condoms provided at no cost at
each visit.
Measures
The baseline questionnaire included sociodemographic
characteristics (e.g., age, highest education, employment
status, and living situation), prior (both lifetime and in
the last four months) recreational drug and alcohol use
(e.g., frequency and type of drugs, erectile dysfunction
medications, and drug use to increase sexual pleasure),
sexual behaviors (e.g., number and gender of steady,
casual, and commercial exchange partners, usual sex-
ual position, condom use, and group sex), and HIV
knowledge and awareness. Prior medical history was
also queried, including prior STI diagnoses and treat-
ment, and men were asked about current anogenital
symptoms.
Interval questionnaires assessed the same drug and
alcohol use and sexual behaviors. From April 2010,
questions regarding Internet use and attendance of
“high parties” were introduced at all visits. High par-
ties are sex parties largely organized ad hoc through
the Internet, characterized by recreational drug use, typic-
ally amphetamine-type stimulants (ATS) or poppers
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(nitrate inhalants), and multiple, often unprotected sexual
encounters with multiple and possibly simultaneous male
partners.
Laboratory testing
HIV testing was performed every four months while
HSV-2 antibody and treponemal and non-treponemal
tests were conducted every 12 months. Interval testing
for bacterial STIs (NG and CT) was performed only for
symptomatic individuals. No intravenous sampling was
undertaken for individuals with negative HIV rapid diag-
nostic tests at non-12 month intervals; thus, retrospect-
ive syphilis and HSV-2 testing for the majority of this
nested sample was not possible.
HIV screening was performed with OraQuick HIV-1/2
Rapid Test (OraSure Technologies, Bethlehem, PA,
USA) on oral fluid, and, if reactive, confirmed with three
rapid tests on serum ((Determine™ HIV-1/2, Abbott
Laboratories, Tokyo, Japan; DoubleCheck™ II HIV-1&2,
Organics, Yavne, Israel (after 02/2011, replaced by SD-
Bioline HIV-1/2 3.0, Standard Diagnostics, Kyonggi-do,
South-Korea); Capillus™ HIV-1/HIV-2, Trinity Biotech,
Jamestown, NY, USA (after 11/2008 replaced by Core™
HIV-1/2, Birmingham, UK)), according to Thai national
guidelines for HIV testing.
HSV-2 testing was by single ELISA test for HSV-2
antibody (HerpeSelect 1 and 2 ELISA, Focus Diagnos-
tics, Cypress, California, USA), with an index cut-off
threshold of 1.1 according to the package insert. No con-
firmatory testing or repeat ELISA for specimens reactive
for HSV-2 was performed. Syphilis was determined with
rapid plasma reagin (RPR) assay (Macro-Vue™ RPR,
Becton Dickinson Microbiology Systems, Sparks, Maryland,
USA); specimens with measurable RPR titre were then
tested with rapid diagnostic test (RDT) for antibody to TP
(Determine™ Syphilis-TP, Abbott Laboratories, Tokyo,
Japan). Persons with RPR ≥ 1:8 and positive RDT were con-
sidered infected with syphilis, consistent with recommenda-
tions by Larsen et al. and used in a previous analysis of
cohort data [17, 18].
Data analysis
Data were analyzed using Stata 11.0 (Stata Corp., College
Station, TX). Descriptive statistics were generated to
characterize the study population negative for prevalent
HIV, HSV-2, and syphilis infection at cohort entry with
at least 12 months follow-up data contribution by
September 13, 2012, at which point 60 % of the cohort
had completed the 60-month visit. For time-dependent
variables, individual contributions were summarized
based on reported behaviors throughout the prior 12-
month interval, concordant with HSV-2 and syphilis
testing schedules; we opted to use this approach due to
the testing algorithm rather than analyze behaviors as
time-varying covariates at 4-month intervals. This ap-
proach necessitated recording a behavior as positive if it
was present at any of the three 4-month follow-up visits
during that period; individuals regarded as negative for a
specific behavior did not report the behavior in three
prior consecutive visits. Continuous variables (e.g., num-
ber of casual partners in last four months) were added
to create a cumulative value for 12 months. Time to in-
fection was grouped at yearly intervals, including HIV,
which was shaped to these intervals. Due to the creation
of these cumulative variables for behaviors or test re-
sults, complementary log-log regression (discrete time
proportional hazards regression) analysis was used to
estimate hazard ratios to best express risk, deemed ap-
propriate for this longitudinal data set [19]. Coefficients
from complementary log-log regression models are dir-
ectly comparable to those of Cox proportional hazards
models, while the hazard ratios produced are compar-
able to logistic models (odds ratios). HSV-2 and syphilis
infections were assumed to have occurred at the mid-
point of the previous year for men with serologic evi-
dence of new infection at a given 12-month interval.
Participants were not censored for a missed visit(s) if
data for a subsequent visit occurred. Time to infection
and risk factors were calculated separately for each in-
fection; participants were not censored from analysis for
any infection.
Incidence densities were calculated and infection-free
periods through 60 months estimated using Kaplan
Meier analysis, with relative time to infection compared
between co-infected individuals using paired t-test. Co-
infections were considered based on presumptive timing
of acquisition and percentages calculated with total
number of either HIV or HSV-2 infections as the
denominator. Complementary log-log regression analysis
with robust standard error estimates was used to
evaluate risk factors for incident HIV, HSV-2, and syph-
ilis infection. For multivariable models, variables corre-
lated at the p ≤ 0.10 level were manually entered into the
model. Final multivariable models retained only those
variables significant at the p ≤ 0.05 level (two-sided alpha
= 0.05) or identified confounders using likelihood-ratio
tests for determining best model fit. Because the variable
“high party attendance” was only assessed after April
2010, separate models only including data following
introduction of this measure were calculated.
Results
Of 1744 baseline cohort participants, 1119/1744 (64.2 %)
had no serologic evidence of HIV, HSV-2, and syphilis at
cohort entry. Of these, 960 (85.8 %) contributed a mini-
mum of 12 months of follow-up data and had interval
testing for all three pathogens. This group differed from
participants not contributing a minimum of 12 months
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and/or with prevalent HIV, HSV-2, or syphilis by higher
levels of education, being more likely to be current stu-
dents and living with family, and less likely to report
binge drinking or drug use (Table 1). Reported sexual
risk behaviors also differed, as uninfected participants
were significantly less likely to have engaged in group
sex, used drugs to enhance sexual pleasure, received
money for sex, and had fewer recent casual male part-
ners at baseline (Table 1).
Incidence of infection and temporal relationships
The total number of infections and incidence density for
HIV, HSV-2, and syphilis were 159 infections and 4.7
cases/100 PY (95 % Confidence Interval (CI): 4.0–5.4),
128 infections and 4.5/100 PY (95 % CI: 3.9–5.5), and 65
infections and 1.9/100 PY (95 % CI: 1.5–2.5), respect-
ively. The person-time contribution for each group
ranged between 2866 and 3423 PY (Fig. 1). Time-to-
event survival curves were quite similar for HSV-2 and
HIV, while syphilis appeared to occur later in the follow-
up time period (Fig. 1). Among those infected with more
than one of the three assessed pathogens during the co-
hort period, mean time to HIV and HSV-2 infection did
not differ (2.5 vs. 2.9 years, p = 0.24) among those with
HIV-HSV-2 co-infection, but time to syphilis infection
was significantly longer than for HSV-2 (3.8 vs. 2.8 years,
p = 0.04) for those with HSV-2-syphilis co-infection and
HIV (4.0 vs. 2.8 years, p < 0.01) for those with HIV-
syphilis co-infection. The number of men acquiring both
HIV and HSV-2 infections (n = 41) was greater than for
HIV and syphilis (n = 32) or HSV-2 and syphilis (n = 23)
infections.
Biologic risk factors for HIV, HSV-2, and syphilis
Biological risk factors for the three infections of interest
are presented in Table 2. The strongest independent pre-
dictor of any single infection in multivariable analysis
was acquisition of another infection; risk of acquiring
HIV or HSV-2 was over three times as great among men
with incident syphilis infection. However, while risk for
HSV-2 independently increased after HIV acquisition
during the cohort period, HSV-2 infection following co-
hort entry was not an independent risk factor for subse-
quent HIV acquisition. Among remaining physiologic
predictors, a history of anal discharge was independently
predictive only of HIV acquisition, while diagnosis of a
bacterial STI was independently predictive of both HSV-
2 and syphilis. Prevalent HSV-1 infection was predictive
for HSV-2 acquisition, but was negatively associated
with HIV acquisition.
Behavioral risk factors for HIV, HSV-2, and syphilis
There were no behavioral risk factors independently pre-
dictive of more than one infection. Independent
predictors of HIV were receptive anal intercourse (RAI),
meeting partners on the Internet, young age, and group
sex during the cohort period (Table 2). Having a trans-
gender partner in the last year, and reporting casual sex
in one’s home or at a sauna were independently predict-
ive of HSV-2 acquisition (Table 2). Risk of syphilis inde-
pendently increased with using drugs to enhance sex
and having more than one steady partner in the past
year, while using condoms with paid partners reduced
risk (Table 2). Sex with female partners, binge drinking,
and level of education were not risk factors for any of
the three pathogens.
Role of high party attendance and risk of HIV, HSV-2, and
syphilis
Risk associated with high party attendance was based on
50 % or fewer observations for each infection outcome.
Risk of HIV (Hazard Ratio (HR) = 3.69, 95 % CI: 2.03–
6.69; 1751 PY), HSV-2 (HR = 2.68, 95 % CI: 1.14–6.29;
1130 PY), and syphilis (HR = 3.18, 95 % CI: 1.33–7.58;
1616 PY) were all statistically significantly higher among
study participants reporting high party attendance in the
last year. In multivariable models, high party attendance
was only independently associated with HIV acquisition
(Adjusted Hazard Ratio = 3.25, 95 % CI: 1.67–6.31), but
not with acquisition of HSV-2 or syphilis.
Discussion
Key findings of these analyses included similarly high
HIV and HSV-2 incidence rates, lower incidence of and
significantly longer time to syphilis infection, and low
rates of co-infection between and lack of behavioral risk
factors common to all three pathogens. These findings,
taken with data from other studies, both strengthen and
lend urgency to introduction and scale up of primary
prevention measures, particularly pre-exposure prophy-
laxis, which has been demonstrated to be effective and
feasible in Thailand.[2, 20–22] Initiation of antiretroviral
therapy at diagnosis should be considered for MSM in
Thailand, as a means of prevention as well as care.[23,
24] The lack of chemoprophylaxis for HSV-2 prevention
and absence of one or more behavioral risk factors asso-
ciated with all three infections suggests that behavioral
prevention interventions for MSM in Bangkok need to
be tailored to each specific STI.
Our data require measured consideration as our HIV
testing was more frequent than HSV-2 or syphilis test-
ing, and this practice biased to detection of HIV over
other STIs. HIV screening was performed at every visit
(every four months), while HSV-2 and syphilis screening
were performed annually, resulting in less precision for
defining time to acquisition, and potentially masking
whether one pathogen precedes and facilitates acquisi-
tion of another. This limitation is very important as a
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number of assumptions regarding behaviors over the
12 month period between HSV-2 and syphilis tests that
may have been inaccurate, depending on timing of an in-
cident infection. Analyses assumed infections occurred
at the midpoint of any given interval between tests,
which was substantially longer for HSV-2 and syphilis.
In one study, HSV-2 was noted to pre-date HIV infec-
tion by six months in a small number of MSM co-
infected following cohort entry, a difference not detect-
able with our testing schedule [10]. This difference in
our testing sequence also resulted in relatively lower
contributions of person-time to HSV-2 and syphilis ana-
lyses compared to HIV infection, potentially reducing
the ability to detect common risk behaviors leading to
acquisition. We attempted to reduce this effect by limit-
ing analyses to the same group of individuals who had
testing through the first 12 months of follow-up, which
included testing for HIV, HSV-2, and syphilis. We also
grouped time-varying covariates, such as paying for sex,
into 12-month segments with a positive response at any
of the 4-month interval visits constituting an overall
positive 12-month response. This grouping, in syn-
chrony with the HSV-2 and syphilis testing intervals, re-
sulted in similar reduced likelihood of detecting
associations with incident infection and potential mis-
classification of risk due to the aggregation over the 12-
month period.
Many studies suggest HSV-2 infection facilitates HIV
acquisition [4, 9–12] and incident HSV-2 was an inde-
pendent risk factor for HIV acquisition during the co-
hort period. Other MSM cohort studies have had mixed
results in documenting a temporal relationship between
HIV and HSV-2 infection, as prevalent and incident
HSV-2 increased HIV risk in the United States while
HIV acquisition was not associated with prevalent or in-
cident HSV-2 in a Kenyan cohort [25].
There have been few explorations of time to syphilis
infection as compared to time to HIV infection among
MSM populations. Findings from MSM cohorts in other
settings are inconsistent on this issue; syphilis either pre-
ceded or occurred concurrently with HIV acquisition,
but no incident HIV-syphilis co-infections were detected
in MSM cohorts elsewhere [12, 15, 26]. Synergies
Table 1 Comparison of baseline characteristics of men who
have sex by infection status at cohort entry in Bangkok,





cohort (n = 784)
p-
value
n, % n, %
Age (years): 0.72
18–21 170, 17.7 % 144, 18.4 %
22–29 523, 54.5 % 412, 52. 6 %
≥30 267, 27.8 % 228, 29.1 %
Education: <0.01
Primary 11, 1.1 % 47, 6.0 %
Secondary/Vocational 457, 47.6 % 469, 59.8 %




380, 39.6 % 250, 31.9 %
Employed 545, 56.8 % 491, 62.6 %
Unemployed 35, 3.6 % 43, 5.5 %
Living Situation: <0.01
With family 413, 43.0 % 246, 31.4 %
With partner 128, 13.3 % 133, 17.0 %
Alone/with
roommate
419, 43.6 % 405, 51.7 %
Sexual Identity: 0.44
Homosexual 741, 77.2 % 615, 78.4 %
Bisexual 211, 22.0 % 158, 20.2 %
Transgender 8, 0.8 % 11, 1.4 %
Binge drinking 92, 9.6 % 116, 14.8 % <0.01
Use club drugsb,c 178, 18.5 % 191, 24.4 % <0.01
Use nitrate inhalantsc 152, 15.8 % 168, 21.4 % <0.01
Use drugs to
enhance sexc
135, 14.1 % 171, 21.8 % <0.01
Use erectile dysfunction
drugsc
96, 10.0 % 106, 13.5 % 0.02
Engage in group sexc 320, 33.3 % 301, 38.4 % 0.03
Coerced
into sexc
155, 16.1 % 146, 18.6 % 0.17
Pay for sexc 140, 14.6 % 114, 14.5 % 0.98
Receive money
for sexc




0–2 389, 40.5 % 274, 34.9 %




Consistent (always) 444, 46.3 % 349, 44.5 %
Table 1 Comparison of baseline characteristics of men who
have sex by infection status at cohort entry in Bangkok,
Thailand, 2006–2012 (n = 960) (Continued)
Sometimes 203, 21.1 % 221, 28.2 %
Never 44, 4.6 % 22, 2.8 %
No anal intercourse 269, 28.0 % 192, 24.5 %
aHIV, herpes simplex-2 virus, and syphilis
bClub drugs include cannabis, 3,4-methylenedioxy-N-methylamphetamine
(MDMA or ecstasy), amphetamine, methamphetamine, ketamine, cocaine, and
gamma hydroxy butyrate (GHB)
cIn the last four months from time of enrollment
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between existing HIV infection and syphilis acquisition
have been explored with resultant findings of increased
HIV shedding potentially increasing risk of HIV trans-
mission [5, 27, 28]. However, increased vulnerability to
syphilis infection has not been biologically attributed to
HIV infection, and detecting such an effect for syphilis
or other infections in light of ongoing risk behaviors
after HIV diagnosis remains a challenge [29]. We de-
fined syphilis infection by titres ≥ 1:8 rather than titres ≥
1:4. This decision may have misclassified some entrants
in this analysis, as 11 men had titres of 1:4 with reactive
Treponemal rapid tests. Further, the number of incident
infections may have been underestimated as a further 13
individuals had similar serologic results.
Prevalent HSV-1 independently predicted HIV acquisi-
tion, as detected in the on-study HIV incidence analysis
and among MSM in other settings [2, 30, 31]. However,
prevalent HSV-1 was protective for HSV-2 acquisition,
in contrast to the positive independent association be-
tween prevalent HSV-2 and HSV-1 within this cohort
and in other MSM cohorts [17, 31, 32]. Antibodies to
HSV-1 have not been shown to confer any protective ef-
fect toward HSV-2 acquisition, though they have been
found to reduce severity of initial HSV-2 infection [32].
Our analysis indicated that anal discharge, a probable
rectal bacterial STI symptom, was a significant risk
factor for HIV and HSV-2, and was more strongly asso-
ciated with HIV acquisition than incident HSV-2 or
syphilis.
Reported RAI increased risk of acquisition of all path-
ogens in bivariate analyses, but only HIV risk remained
significantly increased in adjusted analyses. Previously
reported analyses revealed that HIV prevalence and
acquisition were independently associated with rectal
NG or CT at baseline, both of which were detected in
more than 5 % of participants, and with RAI [2, 33]. In a
United States cohort of MSM presenting with rectal NG
or CT, having two or three recurrent infections with
these bacterial pathogens was a more powerful predictor
for HIV acquisition than syphilis diagnosis early in the
cohort period [29]. Reported interval syndromic STI
diagnosis was independently predictive of HSV-2 and
syphilis acquisition but was not associated with HIV ac-
quisition. This disparity may result from increased likeli-
hood of symptoms and consequent diagnosis of urethral
STIs, suggesting a predominance of insertive sexual acts.
No routine screening for NG or CT during follow-up
was performed, hence it cannot be definitively concluded
whether urethral or rectal bacterial STIs increased risk
of HIV, HSV-2, or syphilis.
There were no independent behavioral risk factors
common to both HIV and HSV-2 acquisition. Rising
HIV incidence may be tied to an emerging social
phenomenon known as the “high party” among urban
Thai MSM, which has also been described in the United
States [34–36]. Several statistically significant risk factors
for HIV (e.g., group sex, meeting partners by Internet,
and drug use with sex) are components of the high
party, potentially accounting for why, among three infec-
tions, only HIV acquisition was independently associated
with high party attendance in adjusted analyses. The lack
of reported behaviors that independently increased risk
of all pathogens may reflect under- or mis-reporting,
which we attempted to prevent through ACASI use.
There may also be behavioral risk factors associated with
all pathogens about which we did not inquire or which
Fig. 1 Comparison of time to infection between HSV-2, HIV, and syphilis among a cohort of men who have sex with men in Bangkok, Thailand,
2006–2012 (n = 960)
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Table 2 Factors predictive of HIV, herpes simplex virus 2 (HSV-2), and syphilis acquisition among serologically-negative MSM in
Bangkok, Thailand (2006–2012)
HIV (n = 1031)a HSV-2 (n = 961) Syphilis (n = 970)
Factors HR (95 % CI)b AHR (95 % CI) HR (95 % CI) AHR (95 % CI) HR (95 % CI) AHR (95 % CI)
Age 0.92, 0.89–0.95 0.94, 0.91–0.97 0.97, 0.94–1.01 0.96, 0.90–1.01
Current living situation
With family Reference Reference Reference
With partner 1.25, 0.77–2.05 1.23, 0.72–2.12 1.86, 0.95–3.66
Alone/with roommate 1.52, 1.09–2.13 1.26, 0.87–1.84 1.20, 0.70–2.07
Sexual debut ≥18 years
Yes 0.62, 0.45–0.85 0.63, 0.44–0.90 0.69, 0.41–1.14
No Reference Reference Reference
Usual sexual position
Insertive Reference Reference Reference
Receptive/versatile 1.72, 1.23–2.40 0.94, 0.66–1.33 1.01, 0.62–1.67
Ever coerced into sex
Yes 0.67, 0.47–0.97 0.89, 0.58–1.38 0.63, 0.36–1.12
No Reference Reference Reference
Risk behaviors in the last 12 months:
Used Ecstasy
Yes 2.00, 1.11–3.61 1.87, 0.97–3.60 1.83, 0.66–5.08
No Reference Reference Reference
Used nitrate inhalants (poppers)
Yes 2.32, 1.48–3.62 1.72, 0.99–2.99 2.36, 1.16–4.80
No Reference Reference Reference
Used methamphetamine-type stimulants
Yes 1.71, 1.08–2.72 1.73, 1.04–2.89 2.26, 1.18–4.33
No Reference Reference Reference
Used drugs to enhance sex
Yes 1.68, 1.14–2.47 1.54, 0.99–2.40 2.27, 1.28–4.03 1.85, 1.03–3.33
No Reference Reference Reference
Receptive anal intercourse
Yes 5.70, 3.09–10.5 3.10, 1.66–5.79 1.99, 1.24–3.20 1.99, 1.04–3.82
No Reference Reference Reference
Cleansing after anal intercourse
Yes 0.77, 0.70–0.85 0.88, 0.79–0.97 0.95, 0.87–1.03 0.94, 0.84–1.05
No Reference Reference Reference
Had >1 steady partner
Yes 1.38, 0.94–2.04 2.32, 1.35–3.99 2.74, 1.31–5.71 2.10, 1.00–4.41
No Reference Reference Reference
Casual partner:
0 partner Reference Reference Reference
1 partner 1.42, 0.64–3.18 1.95, 0.92–4.16 1.44, 0.57–3.64
2–4 partners 2.48, 1.41–4.34 1.31, 0.69–2.47 1.33, 0.64–2.77
5–7 partners 2.56, 1.42–4.64 1.58, 0.83–3.02 1.06, 0.45–2.47
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Table 2 Factors predictive of HIV, herpes simplex virus 2 (HSV-2), and syphilis acquisition among serologically-negative MSM in
Bangkok, Thailand (2006–2012) (Continued)
8–14 partners 2.62, 1.48–4.64 1.84, 1.01–3.33 1.46, 0.70–3.03
Had transgender partner
Yes 0.76, 0.34–1.71 2.11, 1.16–3.83 2.07, 1.13–3.77 0.32, 0.04–2.32
No Reference Reference Reference
Had group sex
Yes 1.87, 1.36–2.57 1.51, 1.08–2.10 1.38, 0.95–2.00 1.20, 0.70–2.07
No Reference Reference Reference
Was paid for sex
Yes 1.20, 0.78–1.82 1.71, 1.12–2.63 1.83, 0.96–3.51
No Reference Reference Reference
Consistent condom use:
With steady partner(s)
Yes 0.79, 0.57–1.10 1.00, 0.70–1.44 1.37, 1.04–1.82
No Reference Reference Reference
With casual partner(s)
Yes 1.11, 0.94–1.31 1.19, 0.96–1.48 0.85, 0.66–1.11
No Reference Reference Reference
With paid partner (s)
Yes 0.79, 0.61–1.03 1.04, 0.81–1.33 0.38, 0.17–0.88 0.40, 0.17–0.96
No Reference Reference Reference
With client partner(s)
Yes 1.04, 0.83–1.32 1.31, 1.04–1.65 1.34, 0.94–1.89
No Reference Reference Reference
Places meet partners:
On the internet
Yes 1.80, 1.27–2.56 1.56, 1.11–2.19 1.68, 1.13–2.52 0.93, 0.54–1.62
No Reference Reference Reference
Sauna
Yes 1.79, 1.35–2.38 1.32, 0.90–1.95 0.78, 0.46–1.36
No Reference Reference Reference
Disco
Yes 1.95, 1.47–2.57 1.50, 1.03–2.20 1.02, 0.57–1.82
No Reference Reference Reference
Places for casual sex:
Sauna
Yes 1.66, 1.22–2.26 1.58, 1.12–2.23 1.64, 1.14–2.34 0.80, 0.48–1.32
No Reference Reference Reference
Hotel
Yes 1.18, 0.85–1.64 1.51, 1.05–2.16 1.45, 0.87–2.39
No Reference Reference Reference
Own home
Yes 1.83, 1.34–2.50 1.77, 1.24–2.53 1.48, 1.05–2.10 0.89, 0.53–1.47
No Reference Reference Reference
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were not included, particularly structural and social
network-level factors.
There are additional limitations to this study that
require consideration. First, participants represented
a convenience sample and may not be perfectly rep-
resentative of either the entire cohort population or
of the MSM population in Bangkok. Next, some var-
iables were introduced during follow-up interviews,
with consequent reduction in observations regarding
these behaviors. An important example of this is high
party attendance, for which power was limited to detect
associations with incident infections due to reduced
follow-up time when limiting the dataset to those visits at
which this exposure was assessed. Last, in addition to dif-
ferences between testing intervals for the three pathogens,
antibody screening tests were used to detect new HIV and
HSV-2 infection, potentially delaying detection due to
time required for immune antibody response and reduced
sensitivity with use of oral fluid for detection of HIV
antibody.
Conclusions
In summary, HIV and HSV-2 had similar high inci-
dence in this cohort; HSV-2 incidence did not predict
HIV incidence, though differences in testing schedule
and limited time frame reduced the ability to assess
this relationship. HIV acquisition did precede syphilis
infection, but it is not clear whether this relationship
is secondary to continued/resumed risk behaviors fol-
lowing HIV diagnosis, to increased susceptibility of
HIV-infected men to syphilis, or to both. Further re-
search is needed to evaluate temporal relationships
between different STIs. Given high STI acquisition in
this Bangkok MSM community, continued screening
for risk factors and STIs are needed, as well as additional
approaches to prevention.
Abbreviations
ACASI, audio computer-assisted self-interview; AHR, adjusted hazard ratio;
ATS, amphetamine-type stimulant; CI, confidence interval; CT, Chlamydia tra-
chomatis; HIV, human immunodeficiency virus; HR, hazard ratio; HSV-2, her-
pes simplex 2 virus; MSM, men who have sex with men; NG, Neisseria
Table 2 Factors predictive of HIV, herpes simplex virus 2 (HSV-2), and syphilis acquisition among serologically-negative MSM in
Bangkok, Thailand (2006–2012) (Continued)
Partner’s home
Yes 1.87, 1.34–2.61 1.39, 0.97–1.98 1.13, 0.69–1.83
No Reference Reference Reference
Anal discharge
Yes 5.66, 2.31–13.9 4.05, 1.65–9.95 4.57, 1.67–12.5 3.53, 0.49–25.3
No Reference Reference Reference
Diagnosed with STI
Yes 1.39, 0.83–2.33 2.32, 1.47–3.64 1.72, 1.09–2.70 4.16, 2.31–7.49 2.73, 1.43–5.22
No Reference Reference Reference
Incident syphilis
Yes 3.54, 1.97–6.36 3.16, 1.73–5.76 4.86, 2.69–8.78 3.49, 1.89–6.42 N/A
No Reference Reference Reference
Incident HSV-2
Yes 1.84, 1.18–2.88 N/A 3.05, 1.80–5.18 1.93, 1.11–3.36
No Reference Reference Reference
Incident HIV
Yes N/A 2.59, 1.69–3.95 2.26, 1.47–3.48 6.03, 3.75–9.69 4.41, 2.65–7.35
No Reference Reference Reference
Prevalent HSV-1
Yes 0.70, 0.51–0.96 0.73, 0.53–0.99 1.49, 1.06–2.08 1.69, 1.20–2.39 0.74, 0.46–1.20
No Reference Reference Reference
AHR adjusted hazard ratio
CI confidence interval
HIV human immunodeficiency virus
HR hazard ratio
HSV-1 herpes simplex virus 1
HSV-2 herpes simplex virus 2
STI sexually transmitted infection
aNumber of participants varies between infections based on the number contributing follow-up data with at least one follow-up test
bOnly factors significant at p < 0.10 are shown in the HR columns, and only factors significant at p < 0.05 are shown in the AHR columns
Thienkrua et al. BMC Infectious Diseases  (2016) 16:340 Page 9 of 11
gonorrhea; PY, person-year; RAI, receptive anal intercourse; RDT, rapid diag-
nostic test; RPR, rapid plasma reagin; STI, sexually transmitted infection; TP,
Treponema pallidum
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